DK380986A - Fremgangsmaade til fremstilling af piperidinderivater - Google Patents

Fremgangsmaade til fremstilling af piperidinderivater Download PDF

Info

Publication number
DK380986A
DK380986A DK380986A DK380986A DK380986A DK 380986 A DK380986 A DK 380986A DK 380986 A DK380986 A DK 380986A DK 380986 A DK380986 A DK 380986A DK 380986 A DK380986 A DK 380986A
Authority
DK
Denmark
Prior art keywords
preparing
procedure
piperide
ingredients
piperide ingredients
Prior art date
Application number
DK380986A
Other languages
English (en)
Other versions
DK169730B1 (da
DK380986D0 (da
Inventor
Erol Ali Faruk
Roger Thomas Martin
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858520153A external-priority patent/GB8520153D0/en
Priority claimed from GB868612579A external-priority patent/GB8612579D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of DK380986D0 publication Critical patent/DK380986D0/da
Publication of DK380986A publication Critical patent/DK380986A/da
Priority to DK199400745A priority Critical patent/DK173902B1/da
Application granted granted Critical
Publication of DK169730B1 publication Critical patent/DK169730B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
DK380986A 1985-08-10 1986-08-08 Arylimidderivater samt fremgangsmåde til fremstilling af arylpiperidincarbinolderivater DK169730B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK199400745A DK173902B1 (da) 1985-08-10 1994-06-22 Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB858520153A GB8520153D0 (en) 1985-08-10 1985-08-10 Chemical process
GB868612579A GB8612579D0 (en) 1986-05-23 1986-05-23 Chemical process
GB8612579 1986-05-23
GB8520153 1986-05-23

Publications (3)

Publication Number Publication Date
DK380986D0 DK380986D0 (da) 1986-08-08
DK380986A true DK380986A (da) 1987-02-11
DK169730B1 DK169730B1 (da) 1995-01-30

Family

ID=26289644

Family Applications (1)

Application Number Title Priority Date Filing Date
DK380986A DK169730B1 (da) 1985-08-10 1986-08-08 Arylimidderivater samt fremgangsmåde til fremstilling af arylpiperidincarbinolderivater

Country Status (17)

Country Link
US (1) US4902801A (da)
EP (1) EP0223334B1 (da)
JP (2) JPH0696551B2 (da)
AU (1) AU582456B2 (da)
BG (1) BG61319B2 (da)
CA (1) CA1310649C (da)
CY (1) CY1708A (da)
DE (1) DE3680184D1 (da)
DK (1) DK169730B1 (da)
ES (2) ES2000603A6 (da)
GR (1) GR862102B (da)
HK (1) HK69793A (da)
IE (1) IE58831B1 (da)
MX (1) MX171822B (da)
NZ (1) NZ217141A (da)
PT (1) PT83179B (da)
SG (1) SG27793G (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK588289D0 (da) * 1989-11-22 1989-11-22 Ferrosan As Ny heterocyklisk kemi
JPH04288059A (ja) * 1991-03-14 1992-10-13 Nippon Paint Co Ltd 複素環化合物及びその製造法
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9305175D0 (en) * 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US6444190B2 (en) 1995-08-03 2002-09-03 Fmc Corporation Reduction compositions and processes for making the same
AU4997096A (en) * 1995-08-03 1997-03-05 Fmc Corporation Reductions using hydrides
ES2121685B1 (es) * 1996-04-10 1999-09-16 Vita Invest Sa Procedimiento para la obtencion de (+)-trans-4(4-fluoro-fenil)-3-hidroximetil-1-metilpiperidina.
JP3446468B2 (ja) 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
US5936090A (en) * 1996-05-24 1999-08-10 Fmc Corporation Processes for the reduction of imide ester functionality
EP0812827B1 (en) * 1996-06-13 2009-09-02 Sumitomo Chemical Company, Limited Piperidine derivative as intermediates for the preparation of paroxetine and process for their preparation
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
AU4651497A (en) * 1996-09-24 1998-04-17 Fmc Corporation Novel reduction compositions and processes for making the same
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
EP0975595B9 (en) * 1997-04-07 2009-09-16 Georgetown University Analogs of cocaine
GB9710004D0 (en) * 1997-05-17 1997-07-09 Knoll Ag Chemical process
ATE279393T1 (de) * 1997-05-29 2004-10-15 Smithkline Beecham Corp Neues verfahren
WO1998056787A1 (en) 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
DE69910691T2 (de) 1998-06-29 2004-07-08 Sumika Fine Chemical Co. Ltd. L-Tartrate von Trans-(-)-4-(4-Fluorphenyl)-3-Hydroxymethyl-Piperidin Verbindungen und Verfahren zu ihrer Herstellung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
EP1124802A1 (en) * 1998-11-02 2001-08-22 Synthon B.V. Process for producing 4-arylpiperidine-3-carbinols and related compounds
GB9915303D0 (en) * 1999-06-30 1999-09-01 Smithkline Beecham Plc Novel process
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
GB9920147D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel process
GB9924882D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel process
GB9924855D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel processes
AU1037701A (en) * 1999-10-20 2001-04-30 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
GB9930577D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Novel process
EP1280775A1 (en) * 2000-05-12 2003-02-05 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
US6833458B2 (en) 2000-06-05 2004-12-21 Development Center For Biotechnology Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
WO2002028834A1 (en) * 2000-10-06 2002-04-11 Smithkline Beecham P.L.C. Process for the preparation of aryl-piperidine carbinols and intermediates thereof
WO2002053537A1 (en) * 2001-01-04 2002-07-11 Ferrer Internacional, S.A. Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
CA2438892A1 (en) * 2001-02-24 2002-09-06 Spurcourt Limited Process of preparing paroxetine and intermediates for use therein
CA2457382A1 (en) * 2001-06-13 2002-12-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of paroxetine substantially free of alkoxy impurities
KR100477048B1 (ko) * 2002-07-05 2005-03-17 임광민 피페리딘 화합물의 새로운 제조방법
WO2004043921A1 (en) * 2002-11-11 2004-05-27 Natco Pharma Limited Novel process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines.
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
CN101205211B (zh) * 2006-12-19 2011-12-14 北京德众万全药物技术开发有限公司 一种盐酸帕罗西汀重要中间体的制备方法
WO2015071831A1 (en) * 2013-11-18 2015-05-21 Piramal Enterprises Limited An improved process for minimising the formation of dehalogenated byproducts
CN104262255A (zh) * 2014-09-22 2015-01-07 四川大学 一种不对称催化合成γ-硝基吡唑酰胺化合物的方法
CN104402800A (zh) * 2014-12-02 2015-03-11 千辉药业（安徽）有限责任公司 一种反式-4-(4-氟苯基)-3-羟甲基-1-甲基哌啶的制备方法
WO2022269643A1 (en) * 2021-06-25 2022-12-29 Vihita Chem Private Limited An improved process for the preparation of intermediate for paroxetine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE625656A (da) * 1961-12-05
NL125654C (da) * 1963-12-17 1900-01-01
US3666746A (en) * 1969-06-25 1972-05-30 Gaf Corp Pyrrolidonylphenyl azo dyestuffs
US3681327A (en) * 1970-07-01 1972-08-01 Exxon Research Engineering Co N-methylenethiophosphate derivatives of 1,3-thiazines and 1,4-thiazanes
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US3947460A (en) * 1974-06-27 1976-03-30 Sandoz, Inc. 5-Hydroxy-5-substituted phenyl-pyrrolidones and piperidinones
EP0047516B1 (en) * 1980-09-04 1984-01-04 Toray Industries, Inc. Propylamine derivative and process of manufacturing the same
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT

Also Published As

Publication number Publication date
PT83179A (en) 1986-09-01
EP0223334A1 (en) 1987-05-27
DK169730B1 (da) 1995-01-30
IE862135L (en) 1987-02-10
BG61319B2 (bg) 1997-05-30
ES2005745A6 (es) 1989-03-16
DE3680184D1 (de) 1991-08-14
PT83179B (pt) 1989-03-30
HK69793A (en) 1993-07-30
IE58831B1 (en) 1993-11-17
JPH0696551B2 (ja) 1994-11-30
US4902801A (en) 1990-02-20
JPS6239566A (ja) 1987-02-20
JPH08809B2 (ja) 1996-01-10
CY1708A (en) 1994-01-14
CA1310649C (en) 1992-11-24
ES2000603A6 (es) 1988-03-01
AU582456B2 (en) 1989-03-23
DK380986D0 (da) 1986-08-08
EP0223334B1 (en) 1991-07-10
SG27793G (en) 1993-05-21
NZ217141A (en) 1989-06-28
GR862102B (en) 1986-12-30
AU6101286A (en) 1987-02-12
JPH07138228A (ja) 1995-05-30
MX171822B (es) 1993-11-17

Similar Documents

Publication Publication Date Title
DK380986A (da) Fremgangsmaade til fremstilling af piperidinderivater
DK162647C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK119086D0 (da) Fremgangsmaade til fremstilling af oligonucleotider
DK165984C (da) Fremgangsmaade til fremstilling af sphingosinderivater
DK160829C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK156085D0 (da) Fremgangsmaade til fremstilling af acetoxyazetidinoner
DK581886A (da) Fremgangsmaade til fremstilling af ionbyttet mordenit
DK436583A (da) Fremgangsmaade til fremstilling af piperidinderivater
DK343386D0 (da) Fremgangsmaade til fremstilling af 2-cyanamino-pyrimidin-derivater
DK361387A (da) Fremgangsmaade til fremstilling af piperidinopyrimidin
DK533287D0 (da) Fremgangsmaade til fremstilling af azetidinoner
DK258886D0 (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK184687D0 (da) Fremgangsmaade til fremstilling af diacetonesorbose
DK509986D0 (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK350288D0 (da) Fremgangsmaade til fremstilling af n-epoxypropyllactamer
DK229986D0 (da) Fremgangsmaade til fremstilling af 2-thiocromenylidenethylacetoacetater
DK987A (da) Fremgangsmaade til fremstilling af tetrachlorpyri- din
DK564985A (da) Fremgangsmaade til fremstilling af alkylthioacetamidiner
DK61091A (da) Fremgangsmaade til fremstilling af 4-phenylpiperidinderivater
DK390887D0 (da) Fremgangsmaade til fremstilling af 7alfa-acetylthiosteroider
DK154220C (da) Fremgangsmaade til fremstilling af etoposid
DK165360C (da) Fremgangsmaade til fremstilling af et immunogent kompleks
DK40284A (da) Fremgangsmaade til fremstilling af n-phosphonmethylglycin
DK521885A (da) Fremgangsmaade til fremstilling af benzopyranotriazoler
DK98287D0 (da) Fremgangsmaade til fremstilling af imidazolylthiophenaldehyder

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired